{"id":"https://openalex.org/W4310127336","doi":"https://doi.org/10.1182/blood-2022-167191","title":"Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience","display_name":"Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310127336","doi":"https://doi.org/10.1182/blood-2022-167191"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-167191","doi":"https://doi.org/10.1182/blood-2022-167191","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-167191","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9665264","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078020117","display_name":"Alexander R. Coltoff","orcid":"https://orcid.org/0000-0003-3563-5236","observed_orcids":["https://orcid.org/0000-0003-3563-5236"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Coltoff","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064778715","display_name":"Andrew H. Lipsky","orcid":"https://orcid.org/0000-0002-7653-4792","observed_orcids":["https://orcid.org/0000-0002-7653-4792"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew H. Lipsky","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044188379","display_name":"Todd Louis Rosenblat","orcid":"https://orcid.org/0000-0002-9769-4832","observed_orcids":["https://orcid.org/0000-0002-9769-4832"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd L. Rosenblat","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E. Amengual","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028207893","display_name":"Mark Lawrence Heaney","orcid":"https://orcid.org/0000-0002-4886-9149","observed_orcids":["https://orcid.org/0000-0002-4886-9149"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark L Heaney","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055703943","display_name":"Joseph Gerard Jurcic","orcid":"https://orcid.org/0000-0002-1671-9998","observed_orcids":["https://orcid.org/0000-0002-1671-9998"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph G. Jurcic","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010100538","display_name":"Nicole Lamanna","orcid":"https://orcid.org/0000-0003-3331-9491","observed_orcids":["https://orcid.org/0000-0003-3331-9491"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Lamanna","raw_affiliation_strings":["1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23096681,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"9893","last_page":"9895"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.673799991607666,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.673799991607666,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.24719999730587006,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9010000228881836},{"id":"https://openalex.org/keywords/covid-19-vaccination","display_name":"COVID-19 vaccination","score":0.9779999852180481},{"id":"https://openalex.org/keywords/booster-vaccination","display_name":"booster vaccination","score":0.7599999904632568},{"id":"https://openalex.org/keywords/antibody-response","display_name":"antibody response","score":0.6759999990463257},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8230000138282776},{"id":"https://openalex.org/keywords/covid-19-mortality","display_name":"COVID-19 mortality","score":0.6520000100135803},{"id":"https://openalex.org/keywords/case-fatality-rate","display_name":"case fatality rate","score":0.6880000233650208},{"id":"https://openalex.org/keywords/symptomatic-infection","display_name":"symptomatic infection","score":0.5019999742507935},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.7289999723434448},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.5879999995231628},{"id":"https://openalex.org/keywords/age-related-mortality-risk","display_name":"age-related mortality risk","score":0.48500001430511475},{"id":"https://openalex.org/keywords/sars-cov-2-variants","display_name":"SARS-CoV-2 variants","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6543347835540771},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5412172675132751},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5247930884361267},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.518830418586731},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5099486112594604},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5014433860778809},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4670965075492859},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.373088538646698},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.27557408809661865},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1852996051311493},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09079381823539734},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2022-167191","doi":"https://doi.org/10.1182/blood-2022-167191","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-167191","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9665264","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9665264","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:9665264","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9665264","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400658161","https://openalex.org/W4312210443","https://openalex.org/W4389247291","https://openalex.org/W4378882790","https://openalex.org/W4296468439","https://openalex.org/W6889937296","https://openalex.org/W4318189304","https://openalex.org/W4206606934","https://openalex.org/W4296530236","https://openalex.org/W4387521826"],"abstract_inverted_index":{"BACKGROUND:":[0],"Patients":[1,154],"with":[2,17,27,48,64,93,129,143,155,173,181,219,365,484,559],"chronic":[3],"lymphocytic":[4],"leukemia":[5],"(CLL)":[6],"are":[7,222],"at":[8,326,354,414],"increased":[9,375],"risk":[10],"of":[11,34,81,137,151,158,190,196,217,252,264,319,357,393,430,453,456,482,557,578,600],"morbidity":[12],"and":[13,25,84,89,132,210,232,242,293,368,418,440,460,479,498,534,590,620,626],"mortality":[14],"after":[15,316,332,342,382,424],"infection":[16,83,138,221],"severe":[18],"adult":[19],"respiratory":[20],"syndrome":[21],"coronavirus":[22,28],"2":[23,263,317,422,454],"(SARS-CoV-2)":[24],"illness":[26],"disease":[29],"2019":[30],"(COVID-19).":[31],"Vaccination":[32],"is":[33,623],"crucial":[35],"importance":[36],"in":[37,61,91,103,111,139,224,274,282,306,470,508,516,526,536,544,555,583,586,603,624],"this":[38,604],"patient":[39,420],"population":[40],"yet":[41],"CLL":[42,159,174,259],"patients":[43,63,92,172,180,184,202,218,228,238,254,275,288,295,309,336,364,395,483,527,537,558,587],"demonstrate":[44],"impaired":[45],"vaccination":[46,88,299,398,532,553,565,602],"responses":[47],"decreased":[49],"ability":[50],"to":[51,86,122,280,379,397,513,551,564,569,596],"produce":[52],"neutralizing":[53],"anti-SARS-CoV-2":[54],"antibodies.":[55],"COVID-19":[56,82,87,410,552],"boosters":[57,90],"increase":[58],"response":[59,85,304,315,339,353,373,533,550,563,576,585],"rates":[60],"most":[62,466],"CLL,":[65,182],"but":[66],"their":[67],"impact":[68],"on":[69,165,400,404],"\"real-word\u201d":[70],"disease-related":[71],"outcomes":[72,80],"warrants":[73],"further":[74],"study.":[75],"Therefore,":[76],"we":[77],"evaluated":[78,161,340],"the":[79,147,372,388,438,465,480,496,509,517,545,598,614],"CLL.":[94,560],"METHODS:":[95],"This":[96,125,561],"was":[97,117,272,321,505],"a":[98,104,112,156,297,355,384,426,451,530,575],"retrospective":[99,166],"cohort":[100],"study":[101],"conducted":[102],"single-center,":[105],"North":[106],"American":[107],"academic":[108],"teaching":[109],"hospital":[110],"large,":[113],"urban":[114],"area.":[115],"Data":[116],"collected":[118],"from":[119,376,613],"January":[120],"2020":[121],"December":[123,152],"2021.":[124,153],"time":[126],"period":[127],"coincided":[128],"SARS-CoV-2":[130],"Alpha":[131],"Delta":[133],"variant":[134,616],"predominant":[135,617],"waves":[136,622],"New":[140],"York":[141],"City,":[142],"Omicron":[144,615],"(BA.1)":[145],"dominating":[146],"last":[148],"two":[149],"weeks":[150],"diagnosis":[157],"were":[160,175,230,235,245,289,311,464,521],"for":[162,188,313],"inclusion":[163],"based":[164],"chart":[167],"review.":[168],"In":[169,346,363],"total,":[170],"338":[171,179],"included.":[176],"RESULTS:":[177],"Of":[178],"252":[183],"(74.6%)":[185],"underwent":[186],"testing":[187,406],"COVID-19,":[189,292],"whom":[191],"57":[192],"(16.9%)":[193],"had":[194,257,337,350,449,529],"evidence":[195,595],"active":[197],"or":[198,403,432],"resolved":[199],"infection.":[200],"10":[201],"tested":[203,312],"positive":[204],"by":[205,208,212],"ECLIA,":[206],"38":[207],"RT-PCR,":[209],"9":[211,243],"both":[213,366,447,471],"detection":[214],"methods.":[215],"Characteristics":[216],"documented":[220,523,531,539],"depicted":[223],"Figure":[225,630],"1A.":[226],"51":[227],"(89.5%)":[229],"symptomatic,":[231],"6":[233,522],"(10.5%)":[234],"asymptomatic.":[236],"24":[237],"(42.1%)":[239],"required":[240],"hospitalization":[241],"deaths":[244,542],"recorded":[246],"(15.6%":[247],"case":[248],"fatality":[249],"rate).":[250],"7":[251],"32":[253],"(21.8%)":[255],"who":[256,267,310,528],"received":[258,269,296,450],"therapy":[260,435],"died,":[261],"versus":[262],"25":[265],"(8.0%)":[266],"never":[268],"therapy.":[270,457],"Mortality":[271],"19.6%":[273],">":[276],"60":[277,285],"years":[278],"compared":[279,512],"0%":[281],"those":[283],"\u2264":[284],"years.":[286],"269":[287],"vaccinated":[290,510],"against":[291],"127":[294],"booster":[298,344,601],"(third":[300],"vaccine":[301,320],"dose).":[302],"The":[303,502],"rate":[305,374,504,577],"114":[307],"evaluable":[308,394],"antibody":[314,338,352,463,562],"doses":[318],"66.6%":[322],"(76/114,":[323],"median":[324,356,452],"assessment":[325],"160":[327],"days":[328,359,423],"[range,":[329],"1-253":[330],"days]":[331],"dose":[333],"#2).":[334],"77":[335],"only":[341],"receiving":[343,383,425],"vaccination.":[345,386,428],"these":[347],"patients,":[348],"70.1%":[349],"an":[351,485],"42":[358],"(range,":[360],"5-145":[361],"days).":[362],"pre-":[367],"post-booster":[369],"data":[370,612],"(n=28),":[371],"46.2%":[377],"(13/28)":[378],"85.7%":[380],"(24/28)":[381],"third":[385,591],"Across":[387],"entire":[389],"cohort,":[390],"74.3%":[391],"(142/191)":[392],"responded":[396],"either":[399],"initial":[401],"evaluation":[402],"serial":[405],"(Figure":[407],"1B-C).":[408],"11":[409],"infections":[411,525],"occurred":[412,543,554],"following":[413],"least":[415],"one":[416,419],"vaccination,":[417],"died":[421],"second":[427,589],"Receipt":[429],"prior":[431],"current":[433],"CLL-directed":[434],"differed":[436,494],"between":[437,495,588],"antibody-positive":[439,497],"negative":[441,499],"groups":[442,448],"(53.5%":[443],"vs":[444,476,492],"77.6%),":[445],"although":[446],"lines":[455],"BTK":[458],"inhibitors":[459],"combination":[461],"venetoclax/anti-CD20":[462],"commonly":[467],"used":[468],"treatments":[469],"groups.":[472],"Median":[473],"IgG":[474,486],"(740":[475],"504":[477],"mg/dL)":[478],"proportion":[481],"level":[487],"<":[488],"700":[489],"mg/dL":[490],"(43.0%":[491],"75.5%)":[493],"groups,":[500],"respectively.":[501],"case-fatality":[503],"9.1%":[506],"(1/11)":[507],"group":[511],"17.8%":[514],"(8/45)":[515],"unvaccinated":[518],"group.":[519,547],"There":[520],"COVID":[524],"none":[535],"without":[538],"response.":[540],"No":[541],"former":[546],"CONCLUSIONS:":[548],"Serologic":[549],"three-quarters":[556],"compares":[566],"very":[567],"favorably":[568],"earlier,":[570],"large":[571],"studies":[572],"that":[573],"reported":[574],"40-50%.":[579],"A":[580],"significant":[581],"improvement":[582],"serologic":[584],"vaccinations":[592],"offers":[593],"real-world":[594],"support":[597],"efficacy":[599],"population.":[605],"An":[606],"additional":[607],"expanded":[608],"analysis":[609],"including":[610],"subsequent":[611],"BA.1,":[618],"BA.2,":[619],"BA.4/5":[621],"progress":[625],"will":[627],"be":[628],"presented.":[629],"1View":[631,634],"largeDownload":[632,635],"PPTFigure":[633],"PPT":[636],"Close":[637],"modal":[638]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}